Chemistry of pyridoxine in drug design


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Pyridoxine and its derivatives, pyridoxamine and pyridoxal, are the three main forms of vitamin B6, which play exceptionally important biological roles in living organisms. The active endogenous metabolites of these molecules, pyridoxal phosphate and pyridoxamine phosphate, are the most important coenzymes involved in a wide range of biochemical reactions necessary for cell activity, due to which pyridoxine and its derivatives are regarded as biologically privileged molecules. Taking into account also the wide possibilities for chemical modification of the pyridoxine structure, it is only natural for medicinal chemists to explore them in the design of novel drugs. This review summarizes the data on the main pharmacologically significant pyridoxine derivatives (including pyridoxamine and pyridoxal derivatives) reported in modern scientifi c and patent sources. Methods for their synthesis, key pharmacological properties, and medicinal chemistry concepts underlying the design of the developing physiologically active compounds are presented. The promising directions for future development of chemistry of physiologically active pyridoxine derivatives are also discussed.

About the authors

Y. G. Shtyrlin

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Author for correspondence.
Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

A. S. Petukhov

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

A. D. Strelnik

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

N. V. Shtyrlin

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

A. G. Iksanova

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

M. V. Pugachev

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

R. S. Pavelyev

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

M. S. Dzyurkevich

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

M. R. Garipov

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008

K. V. Balakin

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Russian Federation, 18 ul. Kremlevskaya, Kazan, 420008


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies